Home/Filings/4/0001178913-25-001539
4//SEC Filing

Galitzer Hillel 4

Accession 0001178913-25-001539

CIK 0001638097other

Filed

Apr 29, 8:00 PM ET

Accepted

Apr 30, 4:22 PM ET

Size

7.4 KB

Accession

0001178913-25-001539

Insider Transaction Report

Form 4
Period: 2025-04-28
Galitzer Hillel
Chief Operating Officer
Transactions
  • Award

    Ordinary Shares, par value NIS 0.0000769 per share

    2025-04-28+26,31690,573 total
  • Award

    Stock Option (right to buy)

    2025-04-28+100,000100,000 total
    Exercise: $2.28Exp: 2025-04-28Ordinary Shares, par value NIS 0.0000769 per share (100,000 underlying)
Footnotes (2)
  • [F1]Represents a grant of stock-settled restricted stock units. The restricted stock units vest ratably on a quarterly basis over a one-year period that began on April 28, 2025.
  • [F2]The options vest over a three-year period with 33% of the options vesting on April 28, 2025, the first anniversary of the vesting commencement date, and the remaining options vesting ratably on a quarterly basis over the remaining three-year period.

Documents

1 file

Issuer

Entera Bio Ltd.

CIK 0001638097

Entity typeother

Related Parties

1
  • filerCIK 0001904740

Filing Metadata

Form type
4
Filed
Apr 29, 8:00 PM ET
Accepted
Apr 30, 4:22 PM ET
Size
7.4 KB